[The costs of schizophrenia]

Area of Science:

• Psychiatry and Mental Health Services Research
• Health Economics
• Public Health Policy

Context:

• Schizophrenia is a leading cause of disability and high healthcare expenditure.
• International research on schizophrenia costs has advanced significantly since the 1950s.
• Germany's mental healthcare system lags in empirical cost data collection for schizophrenia.

Purpose:

• To highlight the economic burden of schizophrenia.
• To review the evolution and methodology of schizophrenia cost studies globally.
• To identify barriers to cost research in Germany's mental healthcare sector.

Summary:

• Schizophrenia's high costs stem from early onset, chronicity, readmissions, and disability.
• Cost studies, crucial for mental health services research, are underdeveloped in Germany.
• Methodological challenges, particularly data access restrictions due to strict privacy laws, impede German cost assessments.

Impact:

• Emphasizes the urgent need for comprehensive cost data in German mental healthcare.
• Suggests that cost containment pressures may necessitate future detailed financial reporting.
• Provides a basis for understanding and addressing the economic impact of schizophrenia in Germany.